Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium

Medicine & Life Sciences

• National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 100%
• Domperidone 86%
• Gastroparesis 84%
• Cohort Studies 41%
• Gastric Emptying 10%
• Therapeutics 10%
• Gastroesophageal Reflux 9%
• Nausea 8%
• Registries 7%
• Health Care Outcome Assessment 6%
• Narcotics 5%
• Group Psychotherapy 4%
• Standard of Care 4%
• Abdominal Pain 4%
• Income 3%
• Body Mass Index 3%
• Databases 2%
• Control Groups 2%